Provectus Receives Novel Synthesis Patent
September 13, 2013 at 06:21 AM EDT
Provectus Pharmaceuticals, Inc. (OTC: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has received U.S Patent No. 8,530,675 by the United States Patent and Trademark Office (USPTO),
